{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:02:52Z","timestamp":1784206972909,"version":"3.55.0"},"reference-count":35,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The pathogenesis of nephrolithiasis in primary hyperparathyroidism (PHPT) remains to be elucidated. The latest guidelines suggest parathyroidectomy in patients with asymptomatic PHPT with hypercalciuria (&amp;gt;\u2005400 mg\/d) and increased stone risk profile.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objective of this work is to evaluate the association of urinary stone risk factors and nephrolithiasis in patients with asymptomatic sporadic PHPT and its clinical relevance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>A total of 157 consecutive patients with sporadic asymptomatic PHPT were evaluated by measurement of serum and 24-hour urinary parameters and kidney ultrasound.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Urinary parameters were tested in the univariate analysis as continuous and categorical variables. Only hypercalciuria and hypomagnesuria were significantly associated with nephrolithiasis in the univariate and multivariate analysis adjusted for age, sex, body mass index, estimated glomerular filtration rate, parathyroid hormone, 25-hydroxyvitamin D, serum calcium, and urine volume (odds ratio, OR 2.14 [1.10-4.56]; P\u2005=\u2005.04; OR 3.06 [1.26-7.43]; P\u2005=\u2005.013, respectively). Hypomagnesuria remained associated with nephrolithiasis in the multivariate analysis (OR 6.09 [1.57-23.5], P\u2005=\u2005.009) even when the analysis was limited to patients without concomitant hypercalciuria. The urinary calcium\/magnesium (Ca\/Mg) ratio was also associated with nephrolithiasis (univariate OR 1.62 [1.27-2.08]; P\u2005=\u2005.001 and multivariate analysis OR 1.74 [1.25-2.42], P\u2005=\u2005.001). Hypomagnesuria and urinary Ca\/Mg ratio had a better, but rather low, positive predictive value compared with hypercalciuria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Hypomagnesuria and urinary Ca\/Mg ratio are each associated with silent nephrolithiasis and have potential clinical utility as risk factors, besides hypercalciuria, for kidney stones in asymptomatic PHPT patients. The other urinary indices that have been commonly thought to be associated with kidney stones in PHPT are not supported by our results.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa233","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T19:29:44Z","timestamp":1588706984000},"page":"e2789-e2795","source":"Crossref","is-referenced-by-count":23,"title":["Hypomagnesuria is Associated With Nephrolithiasis in Patients With Asymptomatic Primary Hyperparathyroidism"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0277-1648","authenticated-orcid":false,"given":"Federica","family":"Saponaro","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Pisa, Pisa, Italy"},{"name":"Endocrinology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Apicella","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mazoni","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Borsari","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pardi","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Di Giulio","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Carlucci","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Scalese","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology, National Council of Research, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Bilezikian","sequence":"additional","affiliation":[{"name":"Metabolic Bone Diseases Unit, Division of Endocrinology, Department of Medicine, College of Physician and Surgeons, Columbia University, New York, New York, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"2021122109212693900_CIT0001","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"2021122109212693900_CIT0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"issue":"2","key":"2021122109212693900_CIT0003","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12020-016-0941-6","article-title":"Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas","volume":"55","author":"Borsari","year":"2017","journal-title":"Endocrine."},{"issue":"2","key":"2021122109212693900_CIT0004","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ando.2015.03.015","article-title":"Epidemiology, pathogenesis of primary hyperparathyroidism: current data","volume":"76","author":"Marcocci","year":"2015","journal-title":"Ann Endocrinol (Paris)."},{"issue":"11","key":"2021122109212693900_CIT0005","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s40618-018-0879-z","article-title":"Clinical presentation and management of patients with primary hyperparathyroidism in Italy","volume":"41","author":"Saponaro","year":"2018","journal-title":"J Endocrinol Invest."},{"issue":"10","key":"2021122109212693900_CIT0006","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122109212693900_CIT0007","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.ki.5002708","article-title":"24-h uric acid excretion and the risk of kidney stones","volume":"73","author":"Curhan","year":"2008","journal-title":"Kidney Int."},{"issue":"5","key":"2021122109212693900_CIT0008","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40618-019-01162-y","article-title":"Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?","volume":"43","author":"Saponaro","year":"2020","journal-title":"J Endocrinol Invest."},{"issue":"1","key":"2021122109212693900_CIT0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0002-9343(99)80080-1","article-title":"Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol","volume":"98","author":"Levy","year":"1995","journal-title":"Am J Med."},{"issue":"3","key":"2021122109212693900_CIT0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/089277901750161638","article-title":"Rethinking the role of urinary magnesium in calcium urolithiasis","volume":"15","author":"Schwartz","year":"2001","journal-title":"J Endourol."},{"issue":"2","key":"2021122109212693900_CIT0011","first-page":"123","article-title":"Magnesium therapy for nephrolithiasis","volume":"18","author":"Massey","year":"2005","journal-title":"Magnes Res."},{"issue":"2","key":"2021122109212693900_CIT0012","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11255-018-2036-1","article-title":"Evaluating the associations between urinary excretion of magnesium and that of other components in calcium stone-forming patients","volume":"51","author":"Tavasoli","year":"2019","journal-title":"Int Urol Nephrol."},{"issue":"3-4","key":"2021122109212693900_CIT0013","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12018-011-9104-8","article-title":"Mechanisms of stone formation","volume":"9","author":"Ratkalkar","year":"2011","journal-title":"Clin Rev Bone Miner Metab."},{"issue":"5695","key":"2021122109212693900_CIT0014","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/bmj.1.5695.529","article-title":"Plasma magnesium concentration in primary hyperparathyroidism","volume":"1","author":"Sutton","year":"1970","journal-title":"Br Med J."},{"issue":"2","key":"2021122109212693900_CIT0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2265.2003.01696.x","article-title":"Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation","volume":"58","author":"Cetani","year":"2003","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2021122109212693900_CIT0016","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12020-016-0931-8","article-title":"Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism","volume":"55","author":"Viccica","year":"2017","journal-title":"Endocrine."},{"issue":"2","key":"2021122109212693900_CIT0017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4081\/aiua.2015.2.105","article-title":"Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group","volume":"87","author":"Prezioso","year":"2015","journal-title":"Arch Ital Urol Androl."},{"issue":"6","key":"2021122109212693900_CIT0018","first-page":"693","article-title":"LithoRisk: a software for calculating and visualising nephrolithiasis risk profiles. Article in Italian","volume":"19","author":"Marangella","year":"2002","journal-title":"G Ital Nefrol."},{"key":"2021122109212693900_CIT0019","article-title":"Clinical guide to laboratory tests","volume-title":"Transfusion.","author":"Bell","year":"2009","edition":"3rd ed"},{"issue":"9","key":"2021122109212693900_CIT0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"issue":"2","key":"2021122109212693900_CIT0021","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/07435800.2018.1431275","article-title":"Occult urolithiasis in asymptomatic primary hyperparathyroidism","volume":"43","author":"Tay","year":"2018","journal-title":"Endocr Res."},{"issue":"9","key":"2021122109212693900_CIT0022","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jc.2018-00923","article-title":"Predictors of renal function and calcifications in primary hyperparathyroidism: a nested case-control study","volume":"103","author":"Ejlsmark-Svensson","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122109212693900_CIT0023","doi-asserted-by":"crossref","first-page":"292953","DOI":"10.1155\/2013\/292953","article-title":"Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators","volume":"2013","author":"Aggarwal","year":"2013","journal-title":"Biomed Res Int."},{"issue":"1","key":"2021122109212693900_CIT0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00240-016-0953-y","article-title":"Do \u201cinhibitors of crystallisation\u201d play any role in the prevention of kidney stones? A critique","volume":"45","author":"Robertson","year":"2017","journal-title":"Urolithiasis."},{"issue":"2","key":"2021122109212693900_CIT0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03345354","article-title":"Risk factors associated to kidney stones in primary hyperparathyroidism","volume":"28","author":"Corbetta","year":"2005","journal-title":"J Endocrinol Invest."},{"key":"2021122109212693900_CIT0026","article-title":"EAU guidelines on urolithiasis","author":"T\u00fcrk","year":"2020"},{"issue":"4","key":"2021122109212693900_CIT0027","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/00365599209181230","article-title":"Urinary excretion of citrate, glycosaminoglycans, magnesium and zinc in relation to age and sex in normal subjects and in patients who form calcium stones","volume":"26","author":"Trinchieri","year":"1992","journal-title":"Scand J Urol Nephrol."},{"issue":"3","key":"2021122109212693900_CIT0028","first-page":"192","article-title":"Is magnesium a marker of disordered mineral metabolism in males with idiopathic recurrent calcium urolithiasis? Observations focussing on fasting magnesiuria and magnesiemia, protein and other substances in urine and plasma","volume":"16","author":"Schmiedl","year":"2003","journal-title":"Magnes Res."},{"issue":"4","key":"2021122109212693900_CIT0029","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1684\/mrh.2018.0429","article-title":"Effect of urine pH and magnesium on calcium oxalate saturation","volume":"30","author":"Ferr\u00e8","year":"2017","journal-title":"Magnes Res."},{"issue":"7","key":"2021122109212693900_CIT0030","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1464-410X.2002.03015.x","article-title":"Magnesium status of patients with renal stones and its effect on urinary citrate excretion","volume":"90","author":"Reungjui","year":"2002","journal-title":"BJU Int."},{"issue":"2","key":"2021122109212693900_CIT0031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/07315724.1982.10718985","article-title":"Effects of magnesium hydroxide in renal stone disease","volume":"1","author":"Johansson","year":"1982","journal-title":"J Am Coll Nutr."},{"issue":"7603","key":"2021122109212693900_CIT0032","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(69)91800-5","article-title":"Urinary excretion of calcium and magnesium in primary hyperparathyroidism","volume":"1","author":"Sutton","year":"1969","journal-title":"Lancet."},{"issue":"10","key":"2021122109212693900_CIT0033","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00467-009-1167-0","article-title":"Assessment of crystallization risk formulas in pediatric calcium stone-formers","volume":"24","author":"Sikora","year":"2009","journal-title":"Pediatr Nephrol."},{"issue":"8","key":"2021122109212693900_CIT0034","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/jc.2011-0569","article-title":"Nephrolithiasis and renal calcifications in primary hyperparathyroidism","volume":"96","author":"Rejnmark","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122109212693900_CIT0035","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-19-0316","article-title":"PARAT Workshop Group. Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus statement from the first European Society of Endocrinology Workshop (PARAT)","volume":"181","author":"Bollerslev","year":"2019","journal-title":"Eur J Endocrinol."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa233\/33172515\/dgaa233.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/8\/e2789\/41829992\/jcem_105_8_e2789.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/8\/e2789\/41829992\/jcem_105_8_e2789.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T09:22:09Z","timestamp":1640078529000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/8\/e2789\/5830733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,5,5]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa233","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,5,5]]}}}